Press review
The essentials of recent medical publications, unpacked by our newsroom into a clear, sourced digest, specialty by specialty.
Cardiology and Vascular MedicineEarly fibrinogen: a lifesaving drip?
By Ana Espino | Published on August 06, 2025 | 2 min read#Fibrinogen #Hemorrhage #Coagulopathy Traumatic hemorrhage is a leading cause of preventable death in patients suffering from severe trauma, particularly in the first few hours after injury. It is often worsened by acute coagulopathy, which arises within minutes of the trauma and contributes to increased bleeding. Among the early abnormaliti
Dermatology and VenereologyJellyfish collagen: a high-value marine resource?
By Ana Espino | Published on August 05, 2025 | 2 min read#Jellyfish #Collagen #Cosmetics #Biomaterial Jellyfish, often perceived as a nuisance, are proliferating massively in the Mediterranean due to climate change and overfishing. This demographic explosion raises ecological and economic concerns. However, it could also represent an unprecedented biotechnological opportunity, notably through the
OncologyMAP2K1: a mutation that responds?
By Ana Espino | Published on August 05, 2025 | 2 min read#Histiocytosis #MAPK #MEK #Cobimetinib #Trametinib #Neoplasia Histiocytoses, such as Erdheim-Chester Disease (ECD) and Rosai-Dorfman Disease (RDD), are rare hematological neoplasms resulting from clonal proliferation of myeloid-derived cells. Long considered inflammatory disorders, they are now reclassified as neoplastic entities due to the
GynecologyPregnancy and the skin: hormonal reflection or clinical warning?
By Ana Espino | Published on August 04, 2025 | 2 min read#Pregnancy #Hormones #Dermatology #Obstetrics Pregnancy induces a cascade of profound hormonal, immunological, and mechanical changes, the effects of which are widely reflected in the skin. These physiological modifications, though often anticipated, can present with striking clinical features. The increase in estrogen, progesterone, and mel
OncologyOncolytic viruses: have solid tumors met their match?
By Ana Espino | Published on August 01, 2025 | 2 min read#Tumor #OncolyticVirus #Oncology #NewTherapy Intermediate to advanced-stage solid tumors represent a major therapeutic challenge. Their limited response to conventional treatments—surgery, chemotherapy, radiotherapy—has created a pressing need for innovative approaches. Among these, oncolytic viruses (OVs) are emerging as a promising option.
InfectiologyHBV: Protecting the liver… without harming the rest?
By Ana Espino | Published on August 01, 2025 | 3 min read#Hepatitis #HBV #Tenofovir #InfectiousDiseases Chronic hepatitis B (CHB) affects nearly 300 million people worldwide and remains a leading cause of cirrhosis and hepatocellular carcinoma. While nucleotide analogs like tenofovir disoproxil fumarate (TDF) are effective in suppressing viral replication, long-term use is associated with signific
InfectiologyThe silent face of autoimmune liver diseases
By Ana Espino | Published on July 31, 2025 | 3 min read #Hepatitis #Immunity #Autoimmunity #HepaticFibrosis Hepatic fibrosis is a common, progressive, and often silent complication of autoimmune liver diseases (AILD), including primary biliary cholangitis (PBC), autoimmune hepatitis (AIH), and primary sclerosing cholangitis (PSC). These conditions are characterized by chronic inflammation that cau
Gastroenterology and HepatologyPancreas + HCV: Risky gamble or new paradigm?
By Ana Espino | Published on July 30, 2025 | 2 min read#HCV #Hepatitis #Pancreas Pancreatic transplantation remains an effective solution for patients with severe type 1 diabetes, but the number of available grafts is still insufficient. In response to this shortage, grafts from donors infected with the hepatitis C virus (HCV) represent an underutilized resource. Historically, transmission of the
InfectiologyHepatitis b & pregnancy: a silent threat?
By Ana Espino | Published on July 30, 2025 | 2 min read#HepatitisB #InfectiousDiseases #Pregnancy Hepatitis B is a viral liver infection that can progress to a chronic form, leading to serious complications such as cirrhosis or hepatocellular carcinoma. In 2022, more than 254 million people were living with the virus, making hepatitis B the second leading cause of infectious mortality worldwide, a
Gastroenterology and HepatologyWhen hepatitis becomes hepatocellular carcinoma
By Lila Rouland | Published on July 29, 2025 | 3 min read#viralhepatitis #hepatocellularcarcinoma #oncology #biomarkers #inflammation Introduction: chronic hepatitis, a driver of hepatocellular carcinoma Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is primarily caused by chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV). These infections lea
InfectiologyHBV: Immunity asleep or awakened?
By Ana Espino | Published on July 29, 2025 | 3 min read#HepatitisB #Immunity #InfectiousDiseases Chronic hepatitis B (CHB) remains a major public health issue, affecting more than 296 million people worldwide. Despite the implementation of effective vaccination campaigns, the hepatitis B virus (HBV) continues to cause severe liver complications, including cirrhosis and hepatocellular carcinoma. Cu
InfectiologyHepatitis C: 5-minute test, accurate results?
By Ana Espino | Published on July 28, 2025 | 3 min read#HepatitisC #Immunity #InfectiousDiseases #Diagnosis Hepatitis C remains a major global health issue, with nearly 50 million people infected worldwide. Although highly effective treatments are now available, screening continues to be a weak link in the care cascade—especially among vulnerable populations such as people who inject drugs (PWID),